Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled Study of the Efficacy and Safety of HY02 Ointment in Subjects With Inflamed Meibomian Gland Dysfunction

NCT03888378 is registered in ClinicalTrials.gov with Hovione Scientia Limited as lead sponsor.

NCT NCT03888378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03888378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled Study of the Efficacy and Safety of HY02 Ointment in Subjects With Inflamed Meibomian Gland Dysfunction
Lead sponsor
Hovione Scientia Limited
Phase
Phase 2
Overall status
Completed
Start date
April 2, 2019
Completion date
February 1, 2021
Enrollment
270 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

meibomian gland dysfunction, mgd-meibomian gland dysfunction